156 related articles for article (PubMed ID: 38736137)
41. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
42. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
43. New developments in the endoscopic surveillance of Barrett's oesophagus.
Bergman JJ; Tytgat GN
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007
[TBL] [Abstract][Full Text] [Related]
44. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
Reid BJ; Blount PL; Feng Z; Levine DS
Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
[TBL] [Abstract][Full Text] [Related]
45. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.
van Sandick JW; van Lanschot JJ; Kuiken BW; Tytgat GN; Offerhaus GJ; Obertop H
Gut; 1998 Aug; 43(2):216-22. PubMed ID: 10189847
[TBL] [Abstract][Full Text] [Related]
46. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
[TBL] [Abstract][Full Text] [Related]
47. Fluorescence spectroscopy incorporated in an Optical Biopsy System for the detection of early neoplasia in Barrett's esophagus.
Boerwinkel DF; Holz JA; Hawkins DM; Curvers WL; Aalders MC; Weusten BL; Visser M; Meijer SL; Bergman JJ
Dis Esophagus; 2015; 28(4):345-51. PubMed ID: 24602242
[TBL] [Abstract][Full Text] [Related]
48. Management of high grade dysplasia in Barrett's oesophagus with underlying oesophageal varices: A retrospective study.
Palmer WC; Di Leo M; Jovani M; Heckman MG; Diehl NN; Iyer PG; Wolfsen HC; Wallace MB
Dig Liver Dis; 2015 Sep; 47(9):763-8. PubMed ID: 26066379
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
50. Advanced imaging in surveillance of Barrett's esophagus: Is the juice worth the squeeze?
Cerrone SA; Trindade AJ
World J Gastroenterol; 2019 Jul; 25(25):3108-3115. PubMed ID: 31333304
[TBL] [Abstract][Full Text] [Related]
51. Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus.
Niepsuj K; Niepsuj G; Cebula W; Zieleźnik W; Adamek M; Sielańczyk A; Adamczyk J; Kurek J; Sieroń A
Gastrointest Endosc; 2003 Nov; 58(5):715-9. PubMed ID: 14595307
[TBL] [Abstract][Full Text] [Related]
52. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
53. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.
Fitzgerald RC; di Pietro M; Ragunath K; Ang Y; Kang JY; Watson P; Trudgill N; Patel P; Kaye PV; Sanders S; O'Donovan M; Bird-Lieberman E; Bhandari P; Jankowski JA; Attwood S; Parsons SL; Loft D; Lagergren J; Moayyedi P; Lyratzopoulos G; de Caestecker J;
Gut; 2014 Jan; 63(1):7-42. PubMed ID: 24165758
[TBL] [Abstract][Full Text] [Related]
54. Automated cytological detection of Barrett's neoplasia with infrared spectroscopy.
Old O; Lloyd G; Isabelle M; Almond LM; Kendall C; Baxter K; Shepherd N; Shore A; Stone N; Barr H
J Gastroenterol; 2018 Feb; 53(2):227-235. PubMed ID: 28501919
[TBL] [Abstract][Full Text] [Related]
55. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma.
Ormeci N; Savas B; Coban S; Palabiyikoğlu M; Ensari A; Kuzu I; Kursun N
Surg Endosc; 2008 Mar; 22(3):693-700. PubMed ID: 17704887
[TBL] [Abstract][Full Text] [Related]
56. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
57. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.
Connor MJ; Sharma P
Thorac Surg Clin; 2004 Feb; 14(1):87-94. PubMed ID: 15382312
[TBL] [Abstract][Full Text] [Related]
58. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
[TBL] [Abstract][Full Text] [Related]
59. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
[TBL] [Abstract][Full Text] [Related]
60. Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus.
Fitzgerald RC; Saeed IT; Khoo D; Farthing MJ; Burnham WR
Dig Dis Sci; 2001 Sep; 46(9):1892-8. PubMed ID: 11575441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
